Biocryst Pharmaceuticals Inc

Industry

Biocryst Pharmaceuticals Inc [BCRX] Revenue clocked in at $557.51 million, down -9.83% YTD: What’s Next?

Annabelle Farmer

Biocryst Pharmaceuticals Inc [NASDAQ: BCRX] loss -8.81% or -0.62 points to close at $6.42 with a heavy trading volume of ...

Companies

Biocryst Pharmaceuticals Inc [BCRX] moved up 4.75: Why It’s Important

Annabelle Farmer

Biocryst Pharmaceuticals Inc [NASDAQ: BCRX] price surged by 4.75 percent to reach at $0.33. A sum of 5780229 shares traded ...

Finance

Market cap of Biocryst Pharmaceuticals Inc [BCRX] reaches 1.55B – now what?

Caleb Clifford

Biocryst Pharmaceuticals Inc [NASDAQ: BCRX] stock went on a downward path that fall over -2.90% on Wednesday, amounting to a ...

DBT News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.